K. Altundag Et Al. , "Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer," BREAST , vol.14, no.5, pp.425, 2005
Altundag, K. Et Al. 2005. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer. BREAST , vol.14, no.5 , 425.
Altundag, K., Altundag, O., Atik, M., Morandi, P., & Gunduz, M., (2005). Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer. BREAST , vol.14, no.5, 425.
Altundag, K Et Al. "Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer," BREAST , vol.14, no.5, 425, 2005
Altundag, K Et Al. "Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer." BREAST , vol.14, no.5, pp.425, 2005
Altundag, K. Et Al. (2005) . "Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer." BREAST , vol.14, no.5, p.425.
@article{article, author={K Altundag Et Al. }, title={Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer}, journal={BREAST}, year=2005, pages={425} }